Top global biopharma drugs by lifetime sales up to 2028
Lipitor, which was introduced by Pfizer back in 1997, is expected to be the drug with the third highest lifetime sales at the end of 2028. As of end-2022, the cholesterol-lowering drug aggregated lifetime sales of 172 billion U.S. dollars, which is expected to increase for some additional six billion dollars until 2028.